Obesity Trial, Recruiting NCT06491537 Sponsor: University of Alabama at Birmingham Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06491537
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have recently had a healthy pregnancy with one baby (not twins or more)
  • People who are between 6 and 16 weeks after giving birth at the time of joining the trial
  • People whose body mass index (a measure of body weight relative to height) is 25 or above at the time of joining
  • People who are willing to give their consent to participate

Who may not be able to join:

  • People who have a major health condition they are aware of, such as kidney disease, cancer, or Type 1 or Type 2 diabetes
  • People who are currently receiving treatment for a severe mental health condition, such as schizophrenia
  • People who have been diagnosed with anorexia or bulimia
  • People who are currently taking medication that is likely to significantly affect body weight
  • People who are currently misusing alcohol or other substances
  • People who are already taking part in another diet or weight management program after giving birth
  • People who work overnight shifts more than once a week
  • People who regularly go without eating for 14 hours or more per day, or who have completed 12 or more full-day fasts in the past year
  • People who are not able to understand and communicate in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Camille Worthington, PhD, University of Alabama at Birmingham

Phone: 205.975.7274

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 May 2025
Est. completion
1 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Study Participation Rate; Oral Glucose Tolerance Test (OGTT); Energy Intake; Participant Retention; Change in Visceral Fat; Participant Adherence to Intervention; eTRE Intervention Satisfaction; Change in Body Weight; Change in Subjective Appetite; Self-Reported Fatigue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov